The risk of POAF during hospitalization was numerically lower in patients receiving botulinum toxin rather than saline (36.5% vs 47.8%) but the difference failed to reach statistical significance ...

Patients who develop postoperative A-fib (POAF) after CABG have a lower long-term thromboembolic risk than do patients with nonvalvular A-fib that is not related to recent surgery, a retrospective ...

Eight randomized controlled trials are currently ongoing that will provide further insights into the role of autonomic neuromodulation therapies and POAF prevention after cardiac surgery ...

There was an association between POAF and development of permanent atrial fibrillation (OR, 3.2; 95 percent CI, 1.9 to 5.4; P < 0.001), which was associated with increased risk of neurologic ...

The majority of the present study cohort had at least 10 years of follow-up, during which 50.4% women and 48.9% men with poAF died, compared with 49.6% and 51.1%, respectively, among non-poAF peers.

But a study has found that POAF can significantly increase the risk of heart attack or stroke during the first 12 months after surgery. Skip to main content. Your source for the latest research news.

Botulinum toxin shows promise in trials to reduce post-operative atrial fibrillation (POAF) in cardiac surgery patients. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases ...

There were a total of over 3,600 detected episodes during 2.5 years in those 53 people, with 28.5% of episodes during the early period. Compared with early POAF captured only during the first ...

A 45% greater risk of POAF was found in the SDB group in patients who had elective cardiac surgery (odds ratio, 1.49; 95% CI, 1.30-1.70).

(RTTNews) - AbbVie (ABBV) announced results from its exploratory NOVA phase 2 dose-ranging study evaluating the efficacy and safety of AGN-151607, ...